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The thr~-dimensional structure of the carbohydrate recognition domain of the human E-selectin endotheliai-leuc~yte adhesion molecule (ELAM- 
1) was modelled on the basis of the recently determined X-ray crystallographic structure of the homologous domain found in the rat mannose- 
binding protein. The EGF-like module, which is contiguous to the E-selectin lectin domain, and which is also involved in binding the tetrasaccharide 
ligand, was modelled on the recently determined NMR structure of the EGF-like module of human factor IX. The rule-based homology modelling 
procedures developed at Birkbeck and encoded in the program COMPOSER were used. The model of the two domains combined is discussed in 
terms of cation and ligand binding. 
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1. INTRODUCTION 
E-selectin, or endothelial leucocyte adhesion mole- 
cule-l (ELAM-l), is a mosaic glycoprotein of 610 
amino acids (116 kDa) found on the external membrane 
surface of vascular endothelial cells. It is transiently 
expressed in response to cytokines such as II- 1 and TNF 
[l]. Its function appears to be to recruit neutrophils into 
sites of inflammation. E-selectin is one of a small class 
of ‘selectin’ molecules, all of which have similar primary 
structures, and which include PADGEM (CE62), 
GMP-140, and Leu-8 (TQl or LAM-l). These latter are 
implicated in the “homing’ of leucocytes to the appropri- 
ate lymph nodes. 
From consideration of amino acid sequence the struc- 
ture of E-selectin is believed to consist of a stem of six 
cystine rich repeats (as found in complement regulatory 
proteins) surmounted by an N-terminal lectin domain 
of 119 residues, which has been shown to bind to a 
specific oligosaccharide. There is a single EGF-like 
module connecting this domain to the stem, and the 
bottom of the stem passes via a single transmembrane 
a helix to a small C-terminal cytoplasmic domain. This 
mosaic structure is mirrored at the nucleotide level by 
each separate structural module being coded for by its 
own exon [I]. 
The lectin domain is homologous to a relatively large 
family of C-type (i.e. calcium-dependent) animal lectins 
[2]; versions of this module are found in a variety of 
extracellular mosaic proteins, some soluble, some struc- 
tural, and some membrane bound. 
Correspondence address: A. Mills, Laboratory of Molecular Biology, 
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The specific oligosaccharide counter ligand to E-se- 
lectin is a glycolipid tetrasaccharide known as sialyl- 
Lewis X, the sialylated version of the Lewis X blood 
antigen, with the structure NeuS+Aca2-+3Gu@1+4- 
(Fucal+3)GlcNac [3]. It is constitutively expressed on 
both neutrophils and monocytes. 
Thus far, no X-ray c~stallographic or NMR struc- 
ture determinations have been reported for the E-se- 
lectin molecule. However, the recent determination [4] 
of the X-ray structure of a homologous C-type animal 
lectin domain from the rat mannose-binding protein 
offered the opportunity to build a structural model of 
the E-selectin lectin domain, using well established 
modelling techniques [5-81. The EGF-like domain, 
which joins the lectin module to the stem, is modelled 
on the basis of a set of NMR coordinates for the epider- 
ma1 growth factor-like module from human factor IX 
PI. 
The rat mannose-binding protein carbohydrate rec- 
ognition domains (11.5 residues) show a mixed a + p 
structure with no clear relationship to any previously 
known fold, and with a fair proportion of irregular loop 
structure. There are also two distinct calcium binding 
sites, although in the X-ray structure determination, 
holmium ions were bound. 
This paper describes the process of building the two- 
domain model of E-selectin, and discusses those fea- 
tures of the model which may contribute to ligand and 
cation binding. 
2. METHODS 
2.1. Coordinates 
The crystallographic oordinates of the rat mannose-binding do- 
main (code IMSB) were obtained from the Brookhaven Protein Data- 
Published by Elsevier Science Pub~l~hers 3. V. 5 
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base, January 1992 Release [lO,ll]. In the crystals, the domain exists framework from a structural alignment of the two crystallographically 
as a dimer, and the detailed conformation of some of the loops, and independent copies ofthe known structure, and then built on conform- 
especially the amino- and carboxy-terminal tails, is slightly different ers of the side chains for the E-selectin sequence selected from its 
between the two copies. internal libraries. 
A set of preliminary coordinates for an averaged solution NMR 
structure of the factor IX EGF-like module were distributed (prior to 
release by Brookhaven Protein Data Bank) on computer diskette 
along with the quoted reference [9]. 
2.2. Sequences 
A set of 39 examples of homologous sequences of C-type animal 
lectin domains were extracted from a composite sequence database 
[12], and these were multiply aligned (see Fig. 1) using a Needleman 
and Wunsch-based programme [13]. 
COMPOSER then searched a database of high resolution protein 
structures to find loop fragments which met the appropriate geometric 
criteria for each loop. The retrieved candidate fragments were then 
automatically ranked on criteria of both goodness of fit and on se- 
quence similarity, and filtered for steric clashes with the framework. 
The best selections were accepted, and the side chains for the loops 
were agam built in their most probable conformations. 
As a prerequisite to the structural modelling, an alignment was 
prepared between the sequence of the human E-selectin lectin domain 
and that of the rat mannose-binding structure, exhibiting 27% identity. 
Structural information was brought to bear in confirming the cor- 
rectness of the resultant alignment; the JOY typographical representa- 
tion [14] (see Fig. 2a) was used to reveal this data. An adjustment was 
introduced in the alignment comprising a two-residue shift in the 
section following the second a helix. and includingp strands three and 
four. The sequence identity in ttus region IS very weak, although it 
includes two residues (Asp-161 and Glu-165) in the known structure 
which are involved in metal ion coordination. The alignment from 
sequence alone not only fails to align at least one such coordinating 
residue, but also would require a deletion of two residues at this point 
in the model. The modified alignment (see Fig. 2a) maintains hydro- 
phobic residues at those points in p strands three and four which are 
buried, and avoids the deletion at the coordinating loop. In conse- 
quence. however, a coordinating aspartate in the mannose-binding 
protein is replaced by an isoleucine in the model by this alignment. 
This is discussed further below. 
The crude model was then superimposed on the known structures 
and examined on a computer graphics system using FRODO [IS]. A 
few steric clashes were removed by manual adjustment of side chain 
torsion angles; no adjustment of the polypeptide backbone was neces- 
sary. The conserved isulphides were checked and found to have good 
stereochemistry. The metal-binding sites were then examined, and 
calcium ions inserted into the model at positions almost identical to 
the equivalent holmium ions in the X-ray structure. Manual adjust- 
ment of the coordinating side chains was carried out to optimise the 
coordmation at the binding sites. The whole model was then subjected 
to several rounds of energy mimmisation within SYBYL, usmg its 
default parameters to relieve any steric strain resulting from the mod- 
elling process. 
A similar procedure was followed in the case of the EGF-like model 
using the alignment shown in Fig. 2b, concludmg with a few rounds 
of minimisation; it was apparent that the modelled structure was 
relatively strain-free. 
The modified alignment shows that four insertions were necessary. 
It was clear that these could be accommodated in exposed surface 
loops between secondary structural elements, the two disulphide 
bridges were conserved, and a proline aligned with the only cis-proline 
in the X-ray structure. Apart from the instance already mentioned, all 
existing metal-coordinating residues were either unchanged or conser- 
vatively mutated. 
The two sub-models were brought together on a graphics system, 
and the C-terminal strand from the lectin domain joined to the N- 
terminus of the EGF-like module in such a way as to largely preserve 
the extended conformation of the linking polypeptide. The interface 
region between the two domains was examined for the presence of 
hydrophobic patches which might indicate a common contact area but 
none were apparent. 
No obvious relative orientation for the two domains suggested 
itself. The C-terminus of the EGF-like domain ended up at a point 
furthest from the calcium binding loop of the lectin domain (see Fig. 
3). 
The alignment of the EGF-like module with the sequence of the 
EGF-like domain from human Factor IX preserves their three dis- 
ulphides (see Fig. 2b), and requires no insertion or deletion. 
3. RESULTS AND DISCUSSION 
2.3. Structural modelling 
The COMPOSER suite of modelling software [5-81 was used to 
model E-selectin. The alignment was supplied, along with nominations 
for the boundaries between the structurally conserved regions (SCRs) 
and the loops or structurally variable regions (SVRs), as indicated in 
Fig. 2a. The SVRs were selected to be just wide enough to permit the 
necessary conformational adjustments to accompany the insertions at 
the four loops. COMPOSER extracted the conserved main chain 
The backbone structure of the resultant model is 
shown (Fig. 3). with the four loop insertions in the lectin 
domain indicated. In this modelling exercise no difficul- 
ties were experienced with the COMPOSER method, 
except that it was necessary to nominate manually the 
SCRs and then to adjust the alignment of sequence to 
structure over them. 
An analysis of the main chain 4-w dihedral angles 
Fig. I. Sequence alignment of 39 sequences of C-type animal ectin domains. The Identifying codes (with the exception of ELAMl and RATMABP) 
are as obtained from the OWL composite database [18], except hat they have been truncated by two leters; the sequences are: 1, human E-selectin; 
2, rat mannose-binding protein; 3, human pulmonary surfactant protein A; 4, rabbit pulmonary surfactant protein A; 5. dog pulmonary surfactant 
protein A; 6, rat RATSPD locus 1265bp ssRNA; 7, bovine conglutinin; 8, human mannose-binding protein-C; 9, rat prepulmonary surfactant- 
associated protein A; 10, human tetranectin; 11, reef shark tetranectin analogue; 12, human cartilage specific proteoglycan; 13, bovine cartilage 
specific proteoglycan; 14, chicken cartilage specific proteoglycan; 15, acorn barnacle lectin BRA-3; 16. rat hepatic asialoglycoprotein receptorR2/3; 
17, mouse hepatic asialoglycoprotein receptor 2; 18, human hepatlc asialoglycoprotein receptor H2; 19, rat hepatic asialoglycoprotein receptor 1; 
20, human hepatic asialoglycoprotein receptor H 1; 2 1, rat Gal/GalNac-specific lectm; 22, rat Kupfer cell receptor; 23, human low affinity Ig Fc, 
receptor; 24, mouse low affinity Ig Fc, receptor; 25, chicken hepatic lectin; 26, bovine BOVLE-CAM1 locus 2650bp ssRNA; 27, human LECAM 1 
(Leu-8, GP90-Mel, TQl); 28, human granule membrane protein (GMP140); 29, mouse MUSGMP140A locus 2558bp ssRNA; 30, rat pulmonary 
surfactant-associated protein A; 3 1, human mannose receptor precursor; 32, rattlesnake galactose-specific lectin; 33, polyandrocarpa misakiensis 
lectin; 34, human natural killer protein 2-A; 35, human natural killer protein 2-C; 36, mouse NKR-PI gene-40 protein; 37, mouse NKR-PI gene-34 
protein; 38, mouse NKR-PI gene-2 protein; 39, rat NK-cell receptor Pl. The degree of local conservation, as assessed within a 7-residue wide shding 
window, 1s plotted below the alignment. 
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SCRs are indicated thus :- ------------- -___---__---- 
ELAM ELAMl HUMAN ENDOTHELIAL LEUCOCYTE ADHESION MOLECULE 
RATMAB RAT MANNOSE BINDING PROTEIN LECTIN MODULE 
10 
A 
30 40 50 60 
_________,_________,--_----_-,_________,-----_---,_--___--_,_ 
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* ** * * * *x ic 
RATMAB igk~fFv~11~~r~nptsk\‘kal~~e1r~t\’AIPrfae~”kn1qev-.4~~~AFLGIt~~,t~gqF,” 
BbB;IB/3PBPP o1uL)oac!cl~~oI p/3 ~~~acIacY(I~o( 0 POOOIII?P /7 
cation site --> 11 
======================================== Ll ============== 
__-'_--_-----'--_----_,I;,----__--_-~~~~_______, _________/_________ 
0110 0120 0150 0160 
________~~________~~________~~_______~~~________,_________ 
ELAM \I~GTQKPLTEEAKN\VAPGEPNNRQKDEDC\’EIYIKREKDVGXI~~DEKCSKKKLALCYT. . , 
** ** * *hX **** * * * *** * * * 
RATMABP TV-tggrliy--i~i~kd;P~~hg~g~~~VTIv------~ nCl\tiBlj, scyqas&TAVCKlpa 
d OBbb 333 00/3P b~~ap~O~fi 
cation site --> 2 21 21 22 
L2 ==== L3 ================== Loop 4 
I- ---_--- _/_________,_________ ,_________,_________ 
0180 0190 0200 0210 
ELAM 
FACTOR IX 
I.20 130 140 150 
___,_________,_________,_______l_____ 
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Fig. 2. Sequence alignments of the E-selectin sequence, together with nominatrons of structurally conserved regions as used in the modelling in 
COMPOSER, over the stretches of homology with (a) rat mannose-binding protein (RATMABP), and (b) human epidermal growth factor-like 
domain from human Factor IX. The RATMABP structural features are illustrated using the JOY typographic conventron [20] thus: italrc for 
positive @ angle; UPPER CASE for solvent maccessible residues; lower case for solvent accessible residues; bold type for hydrogen bonds to main 
chain amide; underline for hydrogen bonds to main cham carbonyl; tilde (-) for side chain to side chain hydrogen bonds; cedilla indicates a 
drsulphide bonded residue. The secondary structure is indicated beneath the alignment. and the cation coordinatmg residues below that. Conserved 
residues are indicated by asterisks. The residue numbermg for RATMABP in Fig. 2(a) concurs with that in [lo]. 
8 
Volume 319, number 1,2 FEBS LETTERS March 1993 
Ftg. 3. Stereoscopic view of the backbone of the completed model with a supertmposed ribbon trace for clarity. The dotted spheres indicate the 
calcium ions. The four loops which are the sites of insertions in the lectin domain are indicated. The relative disposition of the lectin and the EGF-like 
domains should be regarded as speculative. 
indicated acceptable stereochemistry angles, but then 
the model’s main chain is very similar to the rat protein 
experimental structure. 
The areas which are likely to be different in fine detail 
are: 
the exact conformations of the modelled loops; 
the fine structure of the calcium coordination sites; 
the relative disposition of the lectin and EGF-like do- 
mains. 
3.1. Calcium coordination sites 
The author is not aware of any available information 
concerning the affinity for calcium of the binding site(s) 
in human E-selectin. 
It can be seen from Fig. 4a that whilst most of the 
coordinating residues at cation binding site 1 are con- 
cerved (or conservatively mutated) between the known 
and modelled sequences, Asp-161 in the rat is mutated 
to an isoleucine in E-selectin. This side chain obviously 
cannot partake in coordinating a metal ion, and the 
implication of this for E-selectin is unclear. It is likely 
that the binding affinity of this site for calcium is consid- 
erably reduced. Another possibility is that the alignment 
of Fig. 2a is incorrect at this point, but this is thought 
to be unlikely, since it cannot be sensibly adjusted to 
improve this particular detail and conserve an oxygen- 
bearing side chain. 
Whilst the coordination is lost from one residue, the 
possibility of a compensating ain is introduced by the 
mutation of Gly-190 to a glutamine in E-selectin; in the 
model this side chain is positioned ‘above’ site 1. Thus, 
a third possibility is that the calcium ion at this site may 
be shifted, and the side chains re-arranged somewhat o 
reform the coordination site at a slightly different loca- 
tion. Further data are needed to clarify this point. 
The coordination at cation site 2 is shown in Fig. 4b; 
It is seen that all coordinating side chains are absolutely 
conserved in the model, except it seems that an addi- 
tional stabilising residue may be gained through the 
mutation of Be-207 to a glutamate. This may then hold 
a coordinating water molecule between its carboxylate 
and the calcium ion. 
As noted by Weis et al. [4], the two cation sites are 
effectively linked: “Glu-193 binds to site 2 with its car- 
boxylate and to site 2 with its main chain carbonyl, and 
Asp-206 binds to site 2 with one of its carboxylate oxy- 
gens and its main chain carbonyl, while its other carbox- 
ylate oxygen atom forms a hydrogen bond with a water 
molecule that serves as a ligand in site 1.” Both these 
residues are conserved in the E-selectin model, and the 
water molecule also is likely to be. 
3.2. Sugar binding considerations 
An analysis of the sequence alignment for the C-type 
lectins in the light of the known structure of the rat 
mannose-binding protein suggests that certain surface 
residues which are moderately conserved yet not in- 
volved in metal coordination, may instead be sugar- 
binding residues. The difficulty is that the various lectin 
sequences in Fig. 1 are expected to exhibit a variety of 
9 
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Fig. 4. Calcium binding sites in E-selectin model (a) site 1, and (b) site 2. The restdue numbering corresponds to that of E-selectin as in Fig. 2a. 
specificities for different sugar structures, and accord- 
ingly, we expect a degree of variation (rather than con- 
servation) of liganding side chains. Nevertheless, Weis 
et al. [4] identified Glu-143, Gly-173, Pro-186, and Gly- 
202 in the rat sequence as likely such candidates. 
In the alignment of Fig. 1 we see that the position 
corresponding to Glu-143 is an aspartate or glutamic 
acid with only one exception among the 39 sequences. 
The cis-Proline- is conserved in all sequences except 
the natural killer group of proteins. Its carbonyl is virtu- 
ally at the ‘tip’ of the molecule, and could be involved 
in ligand binding. 
Indeed, most of the main chain carbonyls and amides 
around the large calcium-stabilised loop are solvent- 
exposed. Taken together with the exposed atoms of the 
side chains around the calcium ions, the result is a re- 
gion excessively rich in hydrogen-bonding potential, a 
factor likely to contribute to the sugar binding potential 
of this domain. 
3.3. Conclusions 
The three-dimensional structure of the carbohydrate 
binding domain of human E-selectin, comprised of its 
lectin domain and its EGF-like module, have been mod- 
elled on the basis of the X-ray structure of the C-type 
lectin domain of rat mannose-binding protein and of the 
10 
solution NMR structure of the EGF-like domain of 
human Factor IX. One of the two potential calcium- 
binding sites is modified from the rat mannose-binding 
protein, and probably has reduced affinity for calcium 
ions. 
At this stage, little could be deduced about the nature 
of the binding of E-selectin to its oligosaccharide ligand. 
However, this model should provide a useful starting 
point for interpreting any new data that may become 
available from NMR and other experiments. 
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NOTE ADDED IN PROOF 
Since initial submission of this paper a full report of a complex of the rat mannose-binding protein with an 
oligosaccharide ligand has been published [16]. It reveals that the 3- and 4-hydroxyl groups of a terminal mannose 
are directly ligated to calcium ion 2 to complete the formation of an Ccoordinate calcium ion complex. The 
simultaneous publication [17] of mutagenesis studies confirms the interpretation of the X-ray results by mutating key 
residues to successfully engineer specificity for galactose rather than mannose. In the selectins all coordinating side 
chains at site 2 are conserved with respect o the mannose-binding proteins. This suggests that the 2- and 3-hydroxyl 
of L-fucose binding to this calcium site may be partly responsible for the specificity of E-selectin for the s-Le” ligand. 
If this is the case then an additional site may be expected to bind the terminal sialic acid. 
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